ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,039, issued on Oct. 7, was assigned to Inna Lavrik (Magdeburg, Germany).
"Activators of caspase-8/c-FLIP L dimerization and their use in cancer therapy" was invented by Inna Lavrik (Magdeburg, Germany), Laura Hillert (Magdeburg, Germany), Nikita Ivanisenko (Magdeburg, Germany) and Vladimir Ivanisenko (Magdeburg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to activators of caspase-8/c-FLIPL dimerization and their use in enhancing the pro-apoptotic activity of the heterodimer and cancer therapy."
The patent was filed on July 16, 2019, under Application No. 17/262,978.
*For further information, including images...